Premier (PINC) Competitors $27.95 -0.30 (-1.06%) Closing price 09/23/2025 04:00 PM EasternExtended Trading$28.18 +0.23 (+0.84%) As of 09/23/2025 06:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PINC vs. HQY, LIF, FOUR, LYFT, QBTS, MARA, WPP, ETSY, AMTM, and STNEShould you be buying Premier stock or one of its competitors? The main competitors of Premier include HealthEquity (HQY), Life360 (LIF), Shift4 Payments (FOUR), Lyft (LYFT), D-Wave Quantum (QBTS), Marathon Digital (MARA), WPP (WPP), Etsy (ETSY), Amentum (AMTM), and StoneCo (STNE). These companies are all part of the "business services" industry. Premier vs. Its Competitors HealthEquity Life360 Shift4 Payments Lyft D-Wave Quantum Marathon Digital WPP Etsy Amentum StoneCo HealthEquity (NASDAQ:HQY) and Premier (NASDAQ:PINC) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership. Is HQY or PINC more profitable? HealthEquity has a net margin of 11.49% compared to Premier's net margin of 2.00%. HealthEquity's return on equity of 12.04% beat Premier's return on equity.Company Net Margins Return on Equity Return on Assets HealthEquity11.49% 12.04% 7.44% Premier 2.00%7.04%3.75% Which has more volatility & risk, HQY or PINC? HealthEquity has a beta of 0.5, indicating that its stock price is 50% less volatile than the S&P 500. Comparatively, Premier has a beta of 0.61, indicating that its stock price is 39% less volatile than the S&P 500. Does the media refer more to HQY or PINC? In the previous week, Premier had 12 more articles in the media than HealthEquity. MarketBeat recorded 22 mentions for Premier and 10 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.30 beat Premier's score of 0.69 indicating that HealthEquity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 8 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Premier 6 Very Positive mention(s) 2 Positive mention(s) 13 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings & valuation, HQY or PINC? HealthEquity has higher revenue and earnings than Premier. HealthEquity is trading at a lower price-to-earnings ratio than Premier, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHealthEquity$1.20B6.74$96.70M$1.6556.88Premier$1.01B2.28$20.27M$0.22127.05 Do institutionals and insiders believe in HQY or PINC? 99.6% of HealthEquity shares are held by institutional investors. Comparatively, 74.4% of Premier shares are held by institutional investors. 1.5% of HealthEquity shares are held by insiders. Comparatively, 1.0% of Premier shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Do analysts recommend HQY or PINC? HealthEquity presently has a consensus price target of $119.77, indicating a potential upside of 27.62%. Premier has a consensus price target of $25.75, indicating a potential downside of 7.87%. Given HealthEquity's stronger consensus rating and higher possible upside, research analysts clearly believe HealthEquity is more favorable than Premier.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HealthEquity 0 Sell rating(s) 1 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 3.00Premier 1 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.86 SummaryHealthEquity beats Premier on 14 of the 17 factors compared between the two stocks. Get Premier News Delivered to You Automatically Sign up to receive the latest news and ratings for PINC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PINC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PINC vs. The Competition Export to ExcelMetricPremierMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.33B$7.70B$5.76B$10.51BDividend Yield2.97%2.76%5.53%4.57%P/E Ratio127.0576.3776.4326.62Price / Sales2.2835.16473.3192.90Price / Cash9.7323.0337.4661.85Price / Book1.516.8213.616.45Net Income$20.27M$245.04M$3.29B$271.57M7 Day Performance5.15%1.38%1.87%2.61%1 Month Performance11.18%2.22%4.03%7.28%1 Year Performance42.67%10.41%77.41%29.60% Premier Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PINCPremier2.3789 of 5 stars$27.95-1.1%$25.75-7.9%+40.5%$2.33B$1.01B127.052,700Trending NewsAnalyst ForecastHQYHealthEquity4.3698 of 5 stars$93.02+0.6%$119.77+28.8%+18.5%$7.97B$1.20B56.383,120Positive NewsInsider TradeLIFLife3601.0419 of 5 stars$102.49+2.2%$86.43-15.7%+163.2%$7.77B$371.48M320.29600FOURShift4 Payments4.6331 of 5 stars$85.98-1.6%$115.21+34.0%-3.0%$7.73B$3.33B31.844,000LYFTLyft4.3552 of 5 stars$20.44+9.8%$17.07-16.5%+73.6%$7.57B$5.79B85.172,934Trending NewsAnalyst ForecastQBTSD-Wave Quantum1.5377 of 5 stars$18.34+3.2%$19.27+5.1%+2,912.9%$6.07B$8.83M-17.463Trending NewsAnalyst ForecastMARAMarathon Digital3.8476 of 5 stars$16.24-0.4%$24.50+50.9%+10.2%$6.04B$656.38M14.639WPPWPP1.7806 of 5 stars$26.58-2.1%N/A-53.1%$5.86B$18.84B4.45108,044Analyst DowngradeHigh Trading VolumeETSYEtsy3.5172 of 5 stars$57.80-1.9%$57.80+14.2%$5.84B$2.81B46.612,400AMTMAmentum3.6087 of 5 stars$22.94-3.8%$27.30+19.0%N/A$5.80B$8.39B58.8253,000STNEStoneCo3.5505 of 5 stars$18.65+2.0%$16.56-11.2%+72.4%$5.23B$2.46B-26.6416,793Positive News Related Companies and Tools Related Companies HealthEquity Alternatives Life360 Alternatives Shift4 Payments Alternatives Lyft Alternatives D-Wave Quantum Alternatives Marathon Digital Alternatives WPP Alternatives Etsy Alternatives Amentum Alternatives StoneCo Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PINC) was last updated on 9/24/2025 by MarketBeat.com Staff From Our PartnersWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredIs This Nvidia’s Next Big Invention? (Picture Inside)Nvidia gave investors a chance to make more than 150 times their money with its AI chips known as graphic proc...InvestorPlace | SponsoredAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Premier, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Premier With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.